Elevated levels of TNS4 are strongly correlated with adverse clinical outcomes and increased tumorigenic potential, thereby implicating TNS4 in HNSCC pathogenesis and underscoring its potential as a prognostic indicator. This evidence concerns the gene TNS4 and head and neck squamous cell carcinoma.